Andra AP-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,100
| Closed | -$2.8M | – | 420 |
|
|
2024
Q1 | $2.8M | Buy |
+8,100
| New | +$2.8M | 0.05% | 321 |
|
|
2023
Q3 | – | Sell |
-24,700
| Closed | -$9.36M | – | 302 |
|
|
2023
Q2 | $9.36M | Buy |
24,700
+3,900
| +19% | +$1.48M | 0.24% | 132 |
|
|
2023
Q1 | $9.96M | Sell |
20,800
-5,600
| -21% | -$2.68M | 0.26% | 116 |
|
|
2022
Q4 | $11.1M | Buy |
26,400
+8,900
| +51% | +$3.74M | 0.34% | 37 |
|
|
2022
Q3 | $7.3M | Buy |
17,500
+2,300
| +15% | +$959K | 0.24% | 151 |
|
|
2022
Q2 | $7.52M | Buy |
+15,200
| New | +$7.52M | 0.22% | 182 |
|
|
2021
Q4 | $6.05M | Sell |
8,000
-3,500
| -30% | -$2.64M | 0.12% | 372 |
|
|
2021
Q3 | $8.58M | Buy |
11,500
+500
| +5% | +$373K | 0.18% | 259 |
|
|
2021
Q2 | $7.09M | Buy |
11,000
+1,700
| +18% | +$1.1M | 0.14% | 345 |
|
|
2021
Q1 | $5.31M | Sell |
9,300
-3,700
| -28% | -$2.11M | 0.12% | 419 |
|
|
2020
Q4 | $7.58M | Sell |
13,000
-1,300
| -9% | -$758K | 0.17% | 293 |
|
|
2020
Q3 | $7.37M | Sell |
14,300
-3,700
| -21% | -$1.91M | 0.2% | 182 |
|
|
2020
Q2 | $8.13M | Buy |
18,000
+4,100
| +29% | +$1.85M | 0.24% | 69 |
|
|
2020
Q1 | $4.87M | Sell |
13,900
-200
| -1% | -$70.1K | 0.18% | 199 |
|
|
2019
Q4 | $5.22M | Buy |
+14,100
| New | +$5.22M | 0.15% | 350 |
|